September 12th, 2017
The National Science Foundation has awarded nearly $20 million to a consortium of universities, including the University of Wisconsin–Madison, to support a new engineering research center, the Center for Cell Manufacturing Technologies (CMaT).
Members of the team working to produce high-quality living therapeutic cells to be used in a broad range of life-saving medical therapies now emerging from research laboratories, include CVRC trainers, William Murphy and Timothy Kamp.
The UW–Madison researchers will focus on two disease applications: induced pluripotent stem cells for making heart muscle, and engineered T cells to combat cancer.
To help with that tall order, CMaT will rely on the combined expertise of UW–Madison’s Stem Cell and Regenerative Medicine Center — co-directed by Murphy and Kamp — and the resources of Waisman Biomanufacturing, a cell and gene product development facility at UW–Madison’s Waisman Center.